Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?When will there be a generic loreev available?When will generic fiasap insulin be available?Xiaflex market launch year?Guselkumab brand name?
See the DrugPatentWatch profile for Dificid
Dificid (fidaxomicin) is used to treat certain types of intestinal infections caused by Clostridioides difficile (also called C. diff) in adults. It is indicated specifically for C. difficile infection (CDI).
It is used to treat C. diff infection, including cases where the infection has come back (recurrent CDI), depending on the specific prescribing indication in your country and the product labeling your clinician follows.
Dificid is not used to treat routine bacterial diarrhea without confirmed or strongly suspected C. diff infection. It targets C. diff in the gut rather than broad-spectrum bacterial infections.
Dificid is an oral medication taken by mouth for a course of therapy prescribed by a clinician for CDI.
DrugPatentWatch.com tracks drug patent and exclusivity information. If you are researching competitive products or timing for potential generic/other entries, check Dificid on DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Dificid :